Sphingomyelins and ceramides: possible biomarkers for dementia?

Loft, Laura M I; Moseholm, Kristine F; Pedersen, Karoline K W; Jensen, Majken K; Koch, Manja; Cronjé, Héléne T

Loft, Laura M I; Moseholm, Kristine F; Pedersen, Karoline K W; Jensen, Majken K; Koch, Manja; Cronjé, Héléne T.

Afiliación

Loft LMI; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Moseholm KF; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Pedersen KKW; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Jensen MK; Department of Public Health, Section of Epidemiology, University of Copenhagen, Copenhagen, Denmark.
Koch M; Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, Massachusetts, USA.
Cronjé HT; Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, Massachusetts, USA.

Curr Opin Lipidol ; 33(1): 57-67, 2022 02 01.

Article en En | MEDLINE | ID: mdl-34879042

Asunto(s)

Enfermedad de Alzheimer; Esfingomielinas; Enfermedad de Alzheimer/diagnóstico; Biomarcadores; Encéfalo/metabolismo; Ceramidas/metabolismo; Humanos; Esfingomielinas/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esfingomielinas / Enfermedad de Alzheimer Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Curr Opin Lipidol Asunto de la revista: BIOQUIMICA Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google